A new chapter begins

A new chapter begins

Learn More
Oliver Wyman Oliver Wyman
search
  • Global
    • Global (English)
  • Africa, India, Middle East
    • India (English)
    • Middle East (English)
    • South Africa (English)
  • Americas
    • Brazil (Português)
    • Canada (English)
    • Canada (Français)
  • Asia Pacific
    • China (中文版)
    • Japan (日本語)
    • Southeast Asia (English)
  • Europe
    • Belgium (English)
    • France (Français)
    • Germany (Deutsch)
    • Italy (Italiano)
    • Netherlands (English)
    • Nordics (English)
    • Portugal (Português)
    • Spain (Español)
    • Switzerland (Deutsch)
    • UK And Ireland (English)
Highlights
    Oliver Wyman
    • Global
      • Global (English)
      Africa, India, Middle East
      • India (English)
      • Middle East (English)
      • South Africa (English)
      Americas
      • Brazil (Português)
      • Canada (English)
      • Canada (Français)
      Asia Pacific
      • China (中文版)
      • Japan (日本語)
      • Southeast Asia (English)
      Europe
      • Belgium (English)
      • France (Français)
      • Germany (Deutsch)
      • Italy (Italiano)
      • Netherlands (English)
      • Nordics (English)
      • Portugal (Português)
      • Spain (Español)
      • Switzerland (Deutsch)
      • UK And Ireland (English)
    • search
      Oliver Wyman
      Highlights
      • menu
        Oliver Wyman
        close
      Oliver Wyman
      Home  // . //  Oliver Wyman Health //  When Healthcare’s Past and Future Collide

      When Healthcare’s Past and Future Collide

      Table of Contents

        Banging Down The New Front Door

        [insert summary]

        [add "Read Entire Article" button to https://health.oliverwyman.com/2018/11/banging-down-the-new-front-door.html]

         

        • Health and Life Sciences
        • Healthcare
        • Transformation

        “Trumpcare” and Health Insurance Markets: A Tale of Two Timelines for Repeal and Replace

        Two scenarios for how repeal and replace changes might unfold.

        What President-Elect Trump’s Unexpected Win Means for BioPharma

        The election results sent biopharma stock soaring. Breaking down what’s really on tap for biopharma over the next four years.

        Calculating ‘Value’ In Healthcare

        New standards for data interoperability could redefine the value proposition for payers, providers, and patients.

        Building a Health Equity Framework for the Pharmaceutical Sector

        Merck executives share their strategy for embedding health equity across the pharma value chain.

        Marsh & McLennan logo

        Marsh McLennan is the leader in risk, strategy and people, helping clients navigate a dynamic environment through four global businesses.

        • Marsh logo
        • Guy Carpenter logo
        • Mercer logo
        • Oliver Wyman logo
        • Share
        • Terms Of Use
        • Privacy Notice
        • Cookie Notice
        • Statement On Accessibility
        • Manage Cookies
        • © 2025 Oliver Wyman, LLC. All Rights Reserved.